aml cell lines molm 13 Search Results


molm-13 acute monocytic leukemia (aml) cell line  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc molm-13 acute monocytic leukemia (aml) cell line
Molm 13 Acute Monocytic Leukemia (Aml) Cell Line, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molm-13 acute monocytic leukemia (aml) cell line/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
molm-13 acute monocytic leukemia (aml) cell line - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
molm-13  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection molm-13
Molm 13, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molm-13/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
molm-13 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human aml cell lines molm-13  (Genentech inc)
90
Genentech inc human aml cell lines molm-13
( A ) Expression of CD33 and CLL1 on the surface of human leukemia cell lines (HL-60, MV4–11, THP-1, <t>U937,</t> <t>MOLM-13)</t> was detected by flow cytometry. The gray line represents the isotype control. ( B ) Expression of CD33 and CLL1 in peripheral blood mononuclear cells (PBMCs, No.=22) and bone marrow (BM, No.=12) of Primary <t>AML</t> patients (down panel). A representative flow plot showed the expression of CD33 and CLL1 in tumor cells from two AML patients (up panel). ( C ) The structure of CD33-CAR-T (targeting CD33), CLL1-CAR-T (targeting CLL1), and CD33-CLL1- CAR-T (targeting both CD33 and CLL1). ( D ) The expression of CD45RO and CD62L on T cells before (un T)and after transduction (CAR-T) were detected using flow cytometry. CAR-T: chimeric antigen receptor T-cells; unT: untransfected T-cells.
Human Aml Cell Lines Molm 13, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human aml cell lines molm-13/product/Genentech inc
Average 90 stars, based on 1 article reviews
human aml cell lines molm-13 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Expression of CD33 and CLL1 on the surface of human leukemia cell lines (HL-60, MV4–11, THP-1, U937, MOLM-13) was detected by flow cytometry. The gray line represents the isotype control. ( B ) Expression of CD33 and CLL1 in peripheral blood mononuclear cells (PBMCs, No.=22) and bone marrow (BM, No.=12) of Primary AML patients (down panel). A representative flow plot showed the expression of CD33 and CLL1 in tumor cells from two AML patients (up panel). ( C ) The structure of CD33-CAR-T (targeting CD33), CLL1-CAR-T (targeting CLL1), and CD33-CLL1- CAR-T (targeting both CD33 and CLL1). ( D ) The expression of CD45RO and CD62L on T cells before (un T)and after transduction (CAR-T) were detected using flow cytometry. CAR-T: chimeric antigen receptor T-cells; unT: untransfected T-cells.

Journal: Blood Transfusion

Article Title: The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia

doi: 10.2450/BloodTransfus.786

Figure Lengend Snippet: ( A ) Expression of CD33 and CLL1 on the surface of human leukemia cell lines (HL-60, MV4–11, THP-1, U937, MOLM-13) was detected by flow cytometry. The gray line represents the isotype control. ( B ) Expression of CD33 and CLL1 in peripheral blood mononuclear cells (PBMCs, No.=22) and bone marrow (BM, No.=12) of Primary AML patients (down panel). A representative flow plot showed the expression of CD33 and CLL1 in tumor cells from two AML patients (up panel). ( C ) The structure of CD33-CAR-T (targeting CD33), CLL1-CAR-T (targeting CLL1), and CD33-CLL1- CAR-T (targeting both CD33 and CLL1). ( D ) The expression of CD45RO and CD62L on T cells before (un T)and after transduction (CAR-T) were detected using flow cytometry. CAR-T: chimeric antigen receptor T-cells; unT: untransfected T-cells.

Article Snippet: Human AML cell lines (Molm-13, THP-1, U937) were sourced from the Genentech Cell Line Repository and cultured in RPMI 1,640 medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamine, and 1% penicillin-streptomycin at 37°C in a 5% CO 2 environment.

Techniques: Expressing, Flow Cytometry, Control, Transduction

( A ) Killing percentages of HL60, U937, THP-1, and MOLM-13 cells by unT, CD33-CLL1-CAR-T, CLL1-CAR-T, and CD33-CAR-T cells after 18 h co-culture in vitro . E: T ratios mean the ratios of the absolute number of CAR-T cells to target cells. ( B ) Cytotoxic effects of CD33-CAR-T, CLL1-CAR-T, and CD33-CLL1-CAR-T on 3 primary AML blasts (based on the expression of CD33 and CLL1) after 18 h co-culture in vitro (E: T=1:4). The data were represented as means ± SD and analyzed by One-way ANOVA and two-tailed unpaired Student’s t-test. *p<0.05; **p<0.01; ***p<0.001, ns, no significance.

Journal: Blood Transfusion

Article Title: The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia

doi: 10.2450/BloodTransfus.786

Figure Lengend Snippet: ( A ) Killing percentages of HL60, U937, THP-1, and MOLM-13 cells by unT, CD33-CLL1-CAR-T, CLL1-CAR-T, and CD33-CAR-T cells after 18 h co-culture in vitro . E: T ratios mean the ratios of the absolute number of CAR-T cells to target cells. ( B ) Cytotoxic effects of CD33-CAR-T, CLL1-CAR-T, and CD33-CLL1-CAR-T on 3 primary AML blasts (based on the expression of CD33 and CLL1) after 18 h co-culture in vitro (E: T=1:4). The data were represented as means ± SD and analyzed by One-way ANOVA and two-tailed unpaired Student’s t-test. *p<0.05; **p<0.01; ***p<0.001, ns, no significance.

Article Snippet: Human AML cell lines (Molm-13, THP-1, U937) were sourced from the Genentech Cell Line Repository and cultured in RPMI 1,640 medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamine, and 1% penicillin-streptomycin at 37°C in a 5% CO 2 environment.

Techniques: Co-Culture Assay, In Vitro, Expressing, Two Tailed Test